Advertisement

Topics

Search Results for "CT P6 Celltrion"

01:07 EDT 1st October 2016 | BioPortfolio

Matching Channels

None

Matching News

Real-world biosimilar data driving physician acceptance, says Celltrion

Biosimilar acceptance among physicians has doubled to 80% since 2013, according to a survey presented at by copycat biologic distributor Celltrion Healthcare.

Inside Celltrion: a biosimilar success story built on landfill

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, ...

Pfizer introduces first and only biosimilar monoclonal antibody therapy

Michael JohnsenHospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Infle...

Celltrion's biosimilar for J&J’s arthritis drug gets UF FDA okay

Korea-based Celltrion (Kosdaq: 068270) has received US regulatory approval for its biosimilar version of the arthritis drug marketed by Johnson & Johnson (NYSE: JNJ) and Merck & Co (NYSE: MRK)...

Celltrion/Pfizer Agree To Wait For Mid-September Inflectra Launch

Celltrion Inc. and Pfizer Inc., who have been waiting to launch their biosimilar Inflectra (infliximab-dyyb) pending an ongoing legal dispute...  

Celltrion/Pfizer's Biosimilar Launch: Three Possible Dates For Inflectra

Pfizer and Celltrion still face patent questions – and a pesky launch notification issue – after the ground-breaking US approval of their biosimilar version of Janssen's Remicade.

Many Firsts As Celltrion/Pfizer’s Inflectra Becomes Second US Biosimilar

Move over Zarxio, there's a new kid in town: Inflectra (infliximab-dyyb), which won the FDA's nod on April 5 as the first monoclonal antibody biosimilar licensed in the US, although it's going to be a...

Inflectra-maker Celltrion to expand biosimilar capacity by 170,000L

Celltrion will invest $275m at its biosimilar production site in Korea to ramp up capacity from 140,000L to 310,000L by 2021.

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement